Actiphage TB uniquely detects active TB
Actiphage TB:
- the only blood-based test that combines phage technology, to detect only active, disease-causing mycobacteria, with traditional qPCR methods.
- leverages phage-based technology that is unique and detects only active TB bacterial cells, inherently leading to the higher specificity than other diagnostic methods.
- is a new, innovative TB diagnostic, is being developed as an incipient TB test and may allow for the scale-up of test-and-treat campaigns.
- may play roles in TB screening across the continuum of TB infection and management of TB drug therapy.
Actiphage has not received market clearance status by the U.S FDA or any other country’s regulatory authority.
Contact Us
General contact form
